A key objective of publicly-funded research is that it should lead to the exploitation of results, which goes one step further than the mere production and dissemination of new scientific knowledge. Such an approach is essential to tackle the “European paradox”: a strong science base but weak innovation performance (exploitation)
The overall aim of this study was to retrace the pathways and analyze the impact factors of successful commercialization of EU-funded R&D projects in industrial technologies. To this end, the research team analysed more than 40 cases of commercialisation processes based on projects funded by former European Framework Programmes. As the reality of organisations and individuals creating positive effects for themselves based on research outcome turned out to be rather complex and multifarious, it became evident that the term ‘commercialisation’ was no longer appropriate. Since commercialisation is often understood as the direct, immediate conversion of research into economic success the research team switched to the concept of (successful) market-oriented exploitation. In general, there is an immense variety of forms of positive economic effects based on research outcome and an equally large variety of (path-) ways to get there.
The study aimed to shed light on the question of how to best fund research projects in the Nanoscience, Nanotechnologies, New Materials and Production Processes (NMP) area to promote and improve the exploitation of results. The report provides recommendations on how to increase the innovation output in the Seventh Framework Programme project cycle and in the future Horizon 2020 Programme and in particular, how to foster innovation at all the stages of the project cycle, expand the exploitation side of projects, and improve the entrepreneurial strategies and capacities of Project Partners.